Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Pneumonia Testing Market, published by KBV research, the LAMEA Pneumonia Testing Market would witness market growth of 11% CAGR during the forecast period (2018 – 2024).
The Brazil market would dominate the LAMEA Immunohistochemistry (IHC) Pneumonia Testing Market by Country 2024; growing at a CAGR of 13.1 % during the forecast period. The Argentina market is expected to witness a CAGR of 14.8% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 13.5% during (2018 - 2024).
The Analyzers market dominated the LAMEA Pneumonia Testing Market by Type 2017, thereby, achieving a market value of $112.8 million by 2024. The Consumables market is expected to witness a CAGR of 11.7% during (2018 - 2024).
The Point-Of-Care (POC) Testing market dominated the South Africa Pneumonia Testing Market by Method 2017, growing at a CAGR of 11 % during the forecast period. The Immunodiagnostics market is expected to witness a CAGR of 11.7% during (2018 - 2024). Additionally, The Molecular Diagnostics market is expected to witness highest CAGR of 12.9% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
LAMEA Pneumonia Testing Market Segmentation
By End User
Unique Offerings from KBV Research